Human retinal hemodynamics following administration of 5-isosorbide mononitrate

Current Eye Research

Volumn 20, Issue 3, 2000, Pages 205-210

  Iannaccone, Alessandro ^a,b   DuPont, Joan ^a   Grunwald, Juan E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Isosorbide mononitrate; Laser Doppler velocimetry; Retinal circulation

Indexed keywords

CORONARY VASODILATING AGENT; ISOSORBIDE 5 NITRATE;

ADULT; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EYE FUNDUS; EYE PHOTOGRAPHY; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; LASER DOPPLER FLOWMETRY; NORMAL HUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD FLOW; RETINA VEIN; VEIN DIAMETER;

EID: 0034074710     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/0271-3683(200003)2031-9FT205     Document Type: Article

References (28)

1. Abrams J. Long-acting nitrates in cardiovascular disease. In: Giles TD, Garbus SB, eds. Use of longer-acting agents in cardiac therapy. Recent advances. Health Care Communications, Inc., 1989:107-128.
2. Schaumann N. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate. Int J Clin Pharmacol Ther Tox. 1989;27:445-453.
3. Abshagen UWP. Pharmacokinetics of isosorbide mononitrate. Am J Cardiol. 1992;70:61G-66G.
4. Hutt V, Theodor R, Pabst G, Bonn R, Fritschi E, Jaeger H. Evaluation of bioavailability and pharmacokinetics of two isosorbide-5-mononitrate preparations in healthy volunteers. J Clin Pharmacol. 1992;32:553-557.
5. Thadani U, Maranda CR, Amsterdam E, Spaccavento L, Friedman RG, Chernoff R, Zellner S, Gorwit J, Hinderaker PH. Lack of pharmacological tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994;120:353-359.
6. Frayser R, Hickam JB. Effect of vasodilator drugs on the retinal blood flow in man. Arch Ophthalmol. 1965; 73:640-642.
7. Hickam JB, Frayser R. Studies of the retinal circulation in man. Observations on vessel diameter, arteriovenous oxygen difference, and mean circulation time. Circulation. 1966;33:302-316.
8. Wizemann A, Maier T, Wizemann V. Wirksamkeit unterschiedlicher Therapieprinzipien bei experimentellen Netzhautgefäß-verschlüssen. Fortschr Ophthalmol. 1983; 80:176-178.
9. Kuritzky S. Nitroglycerin to treat acute loss of vision (letter). N Engl J Med. 1990;323:1428.
10. Charness ME, Liu GT. Central retinal artery occlusion in giant cell arteritis: Treatment with nitroglycerin. Neurology. 1991;41:1698-1699.
11. Sinclair A-M, Hughes AD, Sever PS. Effect of nifedipine and glyceryl trinitrate on retinal blood flow in normal subjects. J Hum Hypertens. 1993;7:399-401.
12. Grunwald JE, DuPont J, Dreyer EB. Effect of chronic nitrate treatment on retinal vessel caliber in open-angle glaucoma. Am J Ophthalmol. 1997;123:753-758.
13. Zurakowski D, Chaturvedi N, Nichols DP, Lipton SA, Dreyer EB. Nitrates slow progression of glaucomatous optic neuropathy (ARVO abstracts). Invest Ophthalmol Vis Sci. 1995;36(Suppl. 4):S219.
14. Zurakowski D, Vorwerk CK, Gorla M, Kanellopoulos AJ, Chaturvedi N, Grosskreutz CL, Lipton SA, Dreyer EB. Nitrate therapy may retard glaucomatous optic neuropathy, perhaps through modulation of glutamate receptors. Vision Res. 1998;38:1489-1494.
15. Grunwald JE, Iannaccone A, DuPont J. Effect of 5-isosorbide mononitrate on the human optic nerve and choroidal circulations. Br J Ophthalmol. 1999;83:162-167.
16. Riva CE, Feke GT. Laser Doppler velocimetry in the measurement of retinal blood flow. In: Goldman L, ed. The Biomedical Laser: Technology and Clinical Applications. New York: Springer-Verlag, 1981:135-161.
17. Riva CE, Grunwald JE, Sinclair SH, Petrig BL. Blood velocity and volumetric flow rate in human retinal vessels. Invest Ophthalmol Vis Sci. 1985;26:1124-32.
18. Grunwald JE, Brucker AJ, Petrig BL, Riva CE. Retinal blood flow regulation adn the clinical response to panretinal photocoagulation in proliferativc diabetic retinopathy. Ophthalmology. 1989;96:1518-1522.
19. Grunwald JE, Brucker AJ, Braunstein SN, Schwartz SS, Baker L, Petrig BL, Riva CE. Strict metabolic control and retinal blood flow in diabetes mellitus. Br J Ophthalmol. 1994;78:598-604.
20. Damon DN, Duling BR. A comparison between mean blood velocities and center-line red cell velocities as measured with a mechanical image streaking velocitometer. Microvasc Res. 1979;17:330-332.
21. Haefliger IO, Flammer J, Luscher TF. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci. 1992;33:2340-2343.
22. Meyer P, Flammer J, Luscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci. 1993;34:3614-3621.
23. Deussen A, Sonntag M, Vogel R. L-arginine-derived nitric oxide: a major determinant of uveal blood flow. Exp Eye Res. 1993;57:129-134.
24. Kitamura Y, Okamura T, Kani K, Toda N. Nitric oxide-mediated retinal arteriolar and arterial dilatation induced by substance P. Invest Ophthalmol Vis Sci. 1993;34:2859-2865.
25. Haefliger IO, Zschauer A, Anderson DR. Relaxation of retinal pericyte contractile tone through the nitric oxidecyclic guanosine monophosphate pathway. Invest Ophthalmol Vis Sci. 1994;35:991-997.
26. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res. 1996;36:2979-2994.
27. Qi X, Guy J. Localization of NADPH diaphorase/nitric oxide synthase in the optic nerve of the normal guinea pig: A light and electron microscopic study. J Comp Neurol. 1996;370:396-404.
28. Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997;115:497-503.